Search

Your search keyword '"Ercan D"' showing total 80 results

Search Constraints

Start Over You searched for: Author "Ercan D" Remove constraint Author: "Ercan D"
80 results on '"Ercan D"'

Search Results

2. Burnout Syndrome Among Dentists in Turkey

3. Türkiye'deki Diş Hekimlerinin Antibiyotik ve Profilaksi Bilgilerinin Değerlendirilmesi

4. Osteoproductivity of Injectable Bone Grafts with and without Ostrich Eggshell Membrane Protein in Rabbit Femur

5. DENTOALVEOLAR YARALANMALARDA ERKEN TEDAVİ UYGULAMASININ PROGNOZ AÇISINDAN ÖNEMİ: OLGU SUNUMU

6. MST2 kinase suppresses rDNA transcription in response to DNA damage by phosphorylating nucleolar histone H2B

7. Origin and invasion of the emerging infectious pathogen Sphaerothecum destruens

8. KOMPLEKS VE KOMPOUND ODONTOMA, 22 VAKA SUNUMU

9. Mapping and performance evaluation of mathematics education research in Turkey: A bibliometric analysis from 2005 to 2021

10. Low-Dose Dietary Phytoestrogen Abrogates Tamoxifen-Associated Mammary Tumor Prevention

11. Fronto-striatal structures related with model-based control as an endophenotype for obsessive–compulsive disorder

12. Two Practical Methods for the Forward Kinematics of 3-3 Type Spatial and 3-RRR Planar Parallel Manipulators

16. Neuroticism and introversion mediates the relationship between probable ADHD and symptoms of Internet gaming disorder: results of an online survey

17. The relationship of internet addiction symptom severity with posttraumatic stress disorder symptoms and impulsivity among Turkish university students

19. Ortaöğretim Öğrencilerinin Yazma Eğilimi Algıları

21. Hip fracture risk and different gene polymorphisms in the turkish population

22. Evidence of threat to European economy and biodiversity following the introduction of an alien pathogen on the fungal–animal boundary

24. Comparison of Depth of Anesthesia in Different Parts of Maxilla When Only Buccal Anesthesia Was Done for Maxillary Teeth Extraction

25. Investigation of the effects of clinical parameters on mortality in patients with necrotizing fasciitis.

26. An Assessment of the Penile Squamous Cell Carcinoma Surfaceome for Biomarker and Therapeutic Target Discovery.

27. Inhibitory effect of whey protein concentrate on SARS-CoV-2-targeted furin activity and spike protein-ACE2 binding in methotrexate-induced lung damage.

28. Oncogenic switch and single-agent MET inhibitor sensitivity in a subset of EGFR -mutant lung cancer.

29. Budding yeast relies on G 1 cyclin specificity to couple cell cycle progression with morphogenetic development.

30. Analysis of Cell Cycle Progression in the Budding Yeast S. cerevisiae.

31. MST2 kinase suppresses rDNA transcription in response to DNA damage by phosphorylating nucleolar histone H2B.

32. Origin and invasion of the emerging infectious pathogen Sphaerothecum destruens.

33. Response Heterogeneity of EGFR and HER2 Exon 20 Insertions to Covalent EGFR and HER2 Inhibitors.

34. Identification of Existing Drugs That Effectively Target NTRK1 and ROS1 Rearrangements in Lung Cancer.

35. Recent advances for the production and recovery methods of lysozyme.

36. Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors.

37. Arterial disease and vascular access in diabetic patients.

38. Effects of fed-batch and continuous fermentations on human lysozyme production by Kluyveromyces lactis K7 in biofilm reactors.

39. Evidence of threat to European economy and biodiversity following the introduction of an alien pathogen on the fungal-animal boundary.

40. EGFR Mutations and Resistance to Irreversible Pyrimidine-Based EGFR Inhibitors.

41. Combined EGFR/MEK Inhibition Prevents the Emergence of Resistance in EGFR-Mutant Lung Cancer.

42. Identification of Oncogenic and Drug-Sensitizing Mutations in the Extracellular Domain of FGFR2.

43. Acquired EGFR C797S mutation mediates resistance to AZD9291 in non-small cell lung cancer harboring EGFR T790M.

44. Current and future trends for biofilm reactors for fermentation processes.

45. Drug-induced death signaling strategy rapidly predicts cancer response to chemotherapy.

46. Tivantinib (ARQ 197) efficacy is independent of MET inhibition in non-small-cell lung cancer cell lines.

47. Identification of recurrent FGFR3-TACC3 fusion oncogenes from lung adenocarcinoma.

48. Pharmacological targeting of the pseudokinase Her3.

49. Hepatitis B virus e antigen (HBeAg) may have a negative effect on dendritic cell generation.

50. Development of covalent inhibitors that can overcome resistance to first-generation FGFR kinase inhibitors.

Catalog

Books, media, physical & digital resources